大北農(002385.SZ):子公司轉基因抗蟲大豆產品獲阿根廷種植許可
格隆匯11月24日丨大北農(002385.SZ)公佈,2022年11月23日(阿根廷當地時間2022年11月22日),阿根廷政府生產勞動部在其官方網站公佈,公司控股子公司北京大北農生物技術有限公司(簡稱“大北農生物技術”)研發的轉基因抗蟲大豆轉化事件DBN8002(DBN-Ø8ØØ2-3)通過安全評價,正式獲批種植許可。這是大北農生物技術繼2019年耐除草劑大豆轉化事件DBN9004(DBN-Ø9ØØ4-6)獲批阿根廷種植許可後,在南美市場取得的又一里程碑式進展。
轉化事件DBN8002是大北農生物技術所研發的第一個抗蟲大豆轉化事件,對南美地區及國內大豆的主要鱗翅目害蟲有優良的控制效果。轉化事件DBN8002與轉化事件DBN9004疊加形成優良的抗蟲耐除草劑複合性狀產品,為合作伙伴和大豆種植户提供更豐富且具有競爭力的性狀產品和技術服務。該抗蟲耐除草劑複合性狀產品在阿根廷規模化商業推廣還需要獲得疊加事件的種植許可和中國進口許可。
大北農生物技術是一家集玉米、大豆等主要農作物生物技術產品研發的高新技術企業。截止公吿披露日,大北農生物技術已獲得12個轉基因抗蟲、耐除草劑玉米生產應用安全證書和1個轉基因耐除草劑大豆生產應用安全證書。
公司表示,獲得的該種植許可,未來在南美區域具有較大的市場轉化應用價值和市場開發潛力,短期內對公司經營不會立即產生重大影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.